JTL
CRMD icon

Jupiter Topco LLC’s CorMedix CRMD Stock Holding History

Jupiter Topco LLC’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Buy
+26,900
New +$213K ﹤0.01% 2390

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jupiter Topco LLC's CRMD Position: Q2 2026 in Review

Jupiter Topco LLC opened a new position in CorMedix (CRMD) in Q2 2026: 26,900 shares worth $211K. The stake represents ﹤0.01% of the portfolio and ranks #2390 among its holdings.

175 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Jupiter Topco LLC held 26,900 shares of CorMedix worth $211K as of Q2 2026.
  • CorMedix was a new Jupiter Topco LLC position in Q2 2026.
  • CorMedix made up ﹤0.01% of Jupiter Topco LLC's portfolio in Q2 2026, its #2390 holding.
  • 175 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Jupiter Topco LLC's 13F filing for Q2 2026, filed 14 Aug 2026.